vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and CPI Card Group Inc. (PMTS). Click either name above to swap in a different company.
CPI Card Group Inc. is the larger business by last-quarter revenue ($153.1M vs $151.7M, roughly 1.0× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 4.8%, a 3.0% gap on every dollar of revenue. On growth, CPI Card Group Inc. posted the faster year-over-year revenue change (22.3% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $35.2M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 16.9%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
NUTX vs PMTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $153.1M |
| Net Profit | $11.8M | $7.3M |
| Gross Margin | 30.4% | 31.5% |
| Operating Margin | 20.4% | 12.0% |
| Net Margin | 7.8% | 4.8% |
| Revenue YoY | -41.1% | 22.3% |
| Net Profit YoY | -80.8% | 8.5% |
| EPS (diluted) | $2.34 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $153.1M | ||
| Q3 25 | $267.8M | $138.0M | ||
| Q2 25 | $244.0M | $129.8M | ||
| Q1 25 | $211.8M | $122.8M | ||
| Q4 24 | $257.6M | $125.1M | ||
| Q3 24 | $78.8M | $124.8M | ||
| Q2 24 | $76.1M | $118.8M | ||
| Q1 24 | $67.5M | $111.9M |
| Q4 25 | $11.8M | $7.3M | ||
| Q3 25 | $55.4M | $2.3M | ||
| Q2 25 | $-17.7M | $518.0K | ||
| Q1 25 | $21.2M | $4.8M | ||
| Q4 24 | $61.6M | $6.8M | ||
| Q3 24 | $-8.8M | $1.3M | ||
| Q2 24 | $-364.0K | $6.0M | ||
| Q1 24 | $-364.0K | $5.5M |
| Q4 25 | 30.4% | 31.5% | ||
| Q3 25 | 57.8% | 29.7% | ||
| Q2 25 | 51.2% | 30.9% | ||
| Q1 25 | 55.9% | 33.2% | ||
| Q4 24 | 55.0% | 34.1% | ||
| Q3 24 | 27.8% | 35.8% | ||
| Q2 24 | 29.7% | 35.7% | ||
| Q1 24 | 15.1% | 37.1% |
| Q4 25 | 20.4% | 12.0% | ||
| Q3 25 | 48.7% | 9.4% | ||
| Q2 25 | 13.8% | 7.3% | ||
| Q1 25 | 38.1% | 11.5% | ||
| Q4 24 | 44.4% | 12.7% | ||
| Q3 24 | 12.3% | 14.3% | ||
| Q2 24 | 7.0% | 12.5% | ||
| Q1 24 | 2.1% | 12.6% |
| Q4 25 | 7.8% | 4.8% | ||
| Q3 25 | 20.7% | 1.7% | ||
| Q2 25 | -7.3% | 0.4% | ||
| Q1 25 | 10.0% | 3.9% | ||
| Q4 24 | 23.9% | 5.4% | ||
| Q3 24 | -11.2% | 1.0% | ||
| Q2 24 | -0.5% | 5.1% | ||
| Q1 24 | -0.5% | 4.9% |
| Q4 25 | $2.34 | $0.62 | ||
| Q3 25 | $7.76 | $0.19 | ||
| Q2 25 | $-2.95 | $0.04 | ||
| Q1 25 | $3.33 | $0.40 | ||
| Q4 24 | $11.56 | $0.56 | ||
| Q3 24 | $-1.72 | $0.11 | ||
| Q2 24 | $-0.07 | $0.51 | ||
| Q1 24 | $-0.08 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $21.7M |
| Total DebtLower is stronger | — | $286.7M |
| Stockholders' EquityBook value | $329.4M | $-17.3M |
| Total Assets | $918.5M | $403.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $21.7M | ||
| Q3 25 | $166.0M | $16.0M | ||
| Q2 25 | $96.7M | $17.1M | ||
| Q1 25 | $84.7M | $31.5M | ||
| Q4 24 | $40.6M | $33.5M | ||
| Q3 24 | $46.9M | $14.7M | ||
| Q2 24 | $40.8M | $7.5M | ||
| Q1 24 | $30.0M | $17.1M |
| Q4 25 | — | $286.7M | ||
| Q3 25 | — | $308.4M | ||
| Q2 25 | — | $310.9M | ||
| Q1 25 | — | $280.7M | ||
| Q4 24 | — | $280.4M | ||
| Q3 24 | — | $280.2M | ||
| Q2 24 | — | $269.7M | ||
| Q1 24 | — | $265.3M |
| Q4 25 | $329.4M | $-17.3M | ||
| Q3 25 | $317.2M | $-25.7M | ||
| Q2 25 | $235.3M | $-29.0M | ||
| Q1 25 | $176.9M | $-29.7M | ||
| Q4 24 | $132.4M | $-35.6M | ||
| Q3 24 | $60.4M | $-42.8M | ||
| Q2 24 | $62.7M | $-44.6M | ||
| Q1 24 | $63.0M | $-48.5M |
| Q4 25 | $918.5M | $403.2M | ||
| Q3 25 | $964.5M | $407.1M | ||
| Q2 25 | $841.0M | $399.8M | ||
| Q1 25 | $761.9M | $351.9M | ||
| Q4 24 | $655.3M | $349.7M | ||
| Q3 24 | $438.5M | $342.3M | ||
| Q2 24 | $422.4M | $321.4M | ||
| Q1 24 | $404.3M | $319.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $39.6M |
| Free Cash FlowOCF − Capex | $69.0M | $35.2M |
| FCF MarginFCF / Revenue | 45.5% | 23.0% |
| Capex IntensityCapex / Revenue | 0.9% | 2.9% |
| Cash ConversionOCF / Net Profit | 5.95× | 5.39× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $41.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $39.6M | ||
| Q3 25 | $99.5M | $10.0M | ||
| Q2 25 | $27.3M | $4.3M | ||
| Q1 25 | $51.0M | $5.6M | ||
| Q4 24 | $54.0K | $26.7M | ||
| Q3 24 | $6.8M | $12.5M | ||
| Q2 24 | $13.3M | $-4.8M | ||
| Q1 24 | $3.1M | $8.9M |
| Q4 25 | $69.0M | $35.2M | ||
| Q3 25 | $99.2M | $5.3M | ||
| Q2 25 | $26.5M | $533.0K | ||
| Q1 25 | $50.9M | $292.0K | ||
| Q4 24 | $-341.0K | $21.6M | ||
| Q3 24 | $6.2M | $11.1M | ||
| Q2 24 | $12.7M | $-6.0M | ||
| Q1 24 | $2.3M | $7.4M |
| Q4 25 | 45.5% | 23.0% | ||
| Q3 25 | 37.0% | 3.8% | ||
| Q2 25 | 10.9% | 0.4% | ||
| Q1 25 | 24.0% | 0.2% | ||
| Q4 24 | -0.1% | 17.3% | ||
| Q3 24 | 7.8% | 8.9% | ||
| Q2 24 | 16.7% | -5.0% | ||
| Q1 24 | 3.4% | 6.6% |
| Q4 25 | 0.9% | 2.9% | ||
| Q3 25 | 0.1% | 3.4% | ||
| Q2 25 | 0.3% | 2.9% | ||
| Q1 25 | 0.0% | 4.3% | ||
| Q4 24 | 0.2% | 4.0% | ||
| Q3 24 | 0.8% | 1.2% | ||
| Q2 24 | 0.7% | 1.0% | ||
| Q1 24 | 1.1% | 1.3% |
| Q4 25 | 5.95× | 5.39× | ||
| Q3 25 | 1.80× | 4.32× | ||
| Q2 25 | — | 8.39× | ||
| Q1 25 | 2.40× | 1.17× | ||
| Q4 24 | 0.00× | 3.94× | ||
| Q3 24 | — | 9.70× | ||
| Q2 24 | — | -0.79× | ||
| Q1 24 | — | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
